Lipella Pharmaceuticals Inc.
LIPO
$0.17
-$0.04-19.30%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.29% | -34.16% | 93.37% | 61.40% | 14.09% |
| Total Receivables | -- | -50.93% | 1.06% | 172.35% | -11.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -63.56% | 19.64% | 47.45% | -49.99% | -19.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.51% | -28.74% | 84.29% | 25.83% | -0.04% |
|
|
|||||
| Total Current Assets | -39.51% | -28.74% | 84.29% | 25.83% | -0.04% |
| Net Property, Plant & Equipment | -4.42% | 765.44% | -42.23% | -29.34% | -22.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -36.84% | -23.39% | 81.61% | 23.79% | -1.10% |
|
|
|||||
| Total Accounts Payable | -23.88% | 55.09% | 1.00% | -15.52% | 157.57% |
| Total Accrued Expenses | 40.98% | -73.41% | 13.21% | 86.42% | -17.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.26% | 78.75% | -49.58% | -32.77% | -24.44% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -13.99% | -3.85% | 2.97% | 7.59% | 45.99% |
|
|
|||||
| Total Current Liabilities | -13.99% | -3.85% | 2.97% | 7.59% | 45.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.09% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -11.89% | 25.97% | 2.97% | 7.59% | 45.99% |
|
|
|||||
| Common Stock & APIC | 0.00% | -0.05% | 20.08% | 12.39% | 8.47% |
| Retained Earnings | -6.98% | -7.97% | -8.52% | -10.37% | -11.60% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -45.74% | -32.79% | 112.52% | 31.56% | -14.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -100.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -100.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.74% | -32.79% | 112.52% | 31.56% | -14.37% |
| Total Preferred Equity | -- | -100.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.74% | -32.79% | 112.51% | 31.57% | -14.37% |
|
|
|||||